Filing Details

Accession Number:
0001127602-19-032229
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-07 18:20:22
Reporting Period:
2019-11-06
Accepted Time:
2019-11-07 18:20:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
318154 Amgen Inc AMGN Biological Products, (No Disgnostic Substances) (2836) 953540776
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1216519 D Ronald Sugar One Amgen Center Drive
Thousand Oaks CA 91320-1799
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-06 2,000 $54.71 16,436 No 4 M Direct
Common Stock Disposition 2019-11-06 2,000 $215.45 14,436 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Nqso (Right to Buy) Disposition 2019-11-06 2,000 $0.00 2,000 $54.71
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2011-08-03 2020-08-03 No 4 M Direct
Footnotes
  1. The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1.
  2. These shares include 1,619 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's common stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.